MétaCan
Menu
← Back to cohort

Phenotypic Characterization of Elderly Onset Inflammatory Bowel Disease: IBD at 60 and Beyond

2017· article· en· W2911327832 on OpenAlexaboutno aff
Uche Nosegbe, B Miller, Jimmy K. Limdi

Bibliographic record

VenueThe American Journal of Gastroenterology · 2017
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineInflammatory bowel diseasePhenotypeDiseaseClinical phenotypeInflammatory Bowel DiseasesImmunologyInternal medicineGeneticsGene

Abstract

fetched live from OpenAlex

Introduction: The incidence of Inflammatory bowel disease (IBD) is increasing globally in all age groups, at a rate outpacing what genetic influences alone might instigate. Data on elderly onset IBD (age 60 and over) are limited. We aimed to study the phenotypic characteristics of elderly-onset IBD. Methods: A retrospective analysis of 142 patients diagnosed with IBD at 60 years or above at our institution between 1995 and 2016 was conducted. Case notes were reviewed to collect data on demographics, disease features and treatment. Results: Of 142 patients 71 were female. Median age was 71 years (range 62-91) and median age at diagnosis was 65 years (range 60-85). 50 patients had Crohn's disease (CD) (35.2%), 81 had Ulcerative colitis (UC) (57.0%) and 11 (7.8%) had IBD-unspecified (IBDU). Montreal classification for UC was: proctitis (E1) in 27, left sided colitis (E2) in 30 and pancolitis (E3) in 22. 2 patients with proctosigmoiditis await classification. Montreal classification for CD was ileal structuring (L1 B2) in 18: colonic (L2 B1 in 14 patients and L2 B2 in 5 patients. Ileo-colonic (L3) disease was found in 12 (7 B1 and 5 B2) patients. At diagnosis 88 patients were prescribed 5ASA's (18 topical and 6 in combination with oral preparations). Corticoteroids were initially prescribed in 44 (31.4%) patients. Azathioprine was used in 3 (2 E3 and 1 L2B2) patients and 3 patients commenced Infliximab at diagnosis (L3B1 & L1B2 CD and E3 UC). At most recent follow up 26 patients were on corticosteroids, 35 on immunomodulation (26 on Azathioprine, 5 on 6MP and 4 on Methotrexate) with a mean time to immunomodulation being 29.4 months (range 0-137). 16 were on biologic therapy (14 Infliximab and 2 Adalimumab) with a mean time to therapy of 33.7 months (range 0 -189 months). 15 patients (10.7%) had surgery related to IBD: 2 UC vs 13 CD with median time to surgery 20 months (range 0 - 132). 2 patients were diagnosed with CD at emergency surgery. Colon cancer was diagnosed in 1 patient with L2B1 CD. 4 deaths occurred: 1 from CLL (not on immunomodulation), 1 klebsiella pneumonia on Azathioprine, 1 from cryptococcal meningitis on Azathioprine and Infliximab and 1 from prostate cancer. Conclusion: We noted a higher prevalence of UC with E2 and E3 disease and a L2 phenotype in CD corroborating with data from the EPIMAD registry. There is an urgent need for more data on disease presentation, natural history and treatment paradigms for the optimal management of elderly patients with IBD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.222
Teacher spread0.217 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicInflammatory Bowel Disease→French-language works237,207→